Full name
MEDSOURCE POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.19.Z - Other research and experimental development on natural sciences and engineering
46.46.Z - Wholesale of pharmaceutical goods
86.90.C - Nurses and midwives activities
86.90.E - Other human health activities notelsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | ||||
Gross profit (loss) | 0 | 0,4 | 0,1 | -81,9 |
EBITDA | 0 | 0,4 | 0,1 | -71 |
Short time liabilities | 0,4 | 0 | 0 | 0 |
Other operating costs | ||||
Income tax | ||||
Equity capital | -0,1 | 0,2 | 0,3 | 78,6 |
Operating profit (EBIT) | 0 | 0,4 | 0,1 | -72,7 |
Assets | 0,3 | 0,8 | 0,8 | -2,3 |
Net profit (loss) | 0 | 0,3 | 0,1 | -83,4 |
Cash | 0 | 0,2 | 0,3 | 73,9 |
Net income from sale | 0,4 | 1,2 | 1,3 | 10,5 |
Liabilities and provisions for liabilities | 0,4 | 0,3 | 0,4 | 25,4 |
Working assets | 0,3 | 0,8 | 0,7 | -10,2 |
Other income costs | ||||
Depreciation | 0 | 0 | 0 | -∞ |
Basic operational activity income | ||||
% | % | % | p.p. | |
Profitability of capital | -45 | 222,4 | 20,7 | -201,7 |
Equity capital to total assets | -19,4 | 18,4 | 33,7 | 15,3 |
Gross profit margin | 8,9 | 31,1 | 5,1 | -26 |
EBITDA Margin | 9,3 | 30,1 | 7,9 | -22,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 345 | 0 | 0 | 0 |
Current financial liquidity indicator | 0.9454545378684998 | 13.692716598510742 | 14.137125968933105 | 0,4 |
Net dept to EBITDA | 1.3687199354171753 | -0.4260155260562897 | -2.7392308712005615 | -2,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane